Kitov Pharmaceuticals Holdings Ltd. ADR | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$7.81 |
Market Cap |
$18.85 M |
Shares Outstanding |
971.89 K |
Public Float |
- |
Address |
One Azrieli Center Tel Aviv TA 670110 Israel |
Employees | - |
Website | http://www.kitovpharma.com |
Updated | 07/08/2019 |
Kitov Pharma Ltd. is a development stage biopharmaceutical company, which engages in drug development. The firm offers Consensi and NT219. Consensi is intended to treat osteoarthritis pain and hyper tension simultaneously, while NT219 is a cancer therapy drug that delivers anti-tumor effects and increasing survical in various cancer models. |